Dihydromyricetin reduces TGF-β via P53 activation-dependent mechanism in hepatocellular carcinoma HepG2 cells

Protein and Peptide Letters

Volumn 24, Issue 5, 2017, Pages 419-424

  Huang, Xiaojie ^a   Lian, Tianming ^a   Guan, Xiaoqian ^b,c   Liu, Bin ^a,d   Hao, Siyuan ^a   Zhang, Jingjing ^a   Bao, Shiting ^a   Tan, Xiaoyu ^a   Zhu, Runzhi ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

^d JINAN UNIVERSITY   (China)

Author keywords

Anti cancer; Apoptosis; Dihydromyricetin; Hepatocellular carcinoma; P53; Proliferation

Indexed keywords

ANTINEOPLASTIC AGENT; DIHYDROMYRICETIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN MDM2; PROTEIN P53; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; FLAVONOL DERIVATIVE; TP53 PROTEIN, HUMAN;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; HEP-G2 CELL LINE; HUMAN; HUMAN CELL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; CELL PROLIFERATION; DRUG EFFECTS; METABOLISM;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL PROLIFERATION; FLAVONOLS; HEP G2 CELLS; HUMANS; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 85020227081     PISSN: 09298665     EISSN: 18755305     Source Type: Journal    
DOI: 10.2174/0929866524666170223143113     Document Type: Article

References (29)

1. Zhang, Q-Y.; Li, R.; Zeng, G-F.; Liu, B.; Liu, J.; Shu, Y.; Liu, Z-K.; Qiu, Z-D.; Wang, D-J.; Miao, H-L. Dihydromyricetin inhibits migration and invasion of hepatoma cells through regulation of MMP-9 expression. World J. Gastroenterol., 2014, 20(29), 10082.
2. Zeng, G.; Liu, J.; Chen, H.; Liu, B.; Zhang, Q.; Li, M.; Zhu, R. Dihydromyricetin induces cell cycle arrest and apoptosis in melanoma SK-MEL-28 cells. Oncol. Rep., 2014, 31(6), 2713-2719.
3. Wang, W.; Yang, Q.; Sun, Z.; Chen, X.; Yang, C.; Ma, X. Editorial: advance of interactions between exogenous natural bioactive peptides and intestinal barrier and immune responses. Curr. Protein Pept. Sci., 2015, 16(5), 297-343.
4. Wu, S.; Liu, B.; Zhang, Q.; Liu, J.; Zhou, W.; Wang, C.; Li, M.; Bao, S.; Zhu, R. Dihydromyricetin reduced Bcl-2 expression via p53 in human hepatoma hepg2 cells. PloS one, 2013, 8(11), e76886.
5. Zhang, Q.; Liu, J.; Liu, B.; Xia, J.; Chen, N.; Chen, X.; Cao, Y.; Zhang, C.; Lu, C.; Li, M. Dihydromyricetin promotes hepatocellular carcinoma regression via a p53 activation-dependent mechanism. Sci. Reports, 2014, 4, 4628.
6. Xia, J.; Guo, S.; Fang, T.; Feng, D.; Zhang, X.; Zhang, Q.; Liu, J.; Liu, B.; Li, M.; Zhu, R. Dihydromyricetin induces autophagy in HepG2 cells involved in inhibition of mTOR and regulating its upstream pathways. Food Chem. Toxicol., 2014, 66, 7-13.
7. Jennings, M.T.; Pietenpol, J.A. The role of transforming growth factor β in glioma progression. J. Neurooncol., 1998, 36(2), 123-140.
8. Dooley, S.; Ten Dijke, P. TGF-β in progression of liver disease. Cell Tissue Res., 2012, 347(1), 245-256.
9. Fan, P.; Li, L.; Rezaei, A.; Eslamfam, S.; Che, D.; Ma, X. Metabolites of dietary protein and peptides by intestinal microbes and their impacts on gut. Curr. Protein Pept. Sci., 2015, 16(7), 646-54.
10. He, L.; Han, M.; Qiao, S.; He, P.; Li, D.; Li, N.; Ma, X. Soybean antigen proteins and their intestinal sensitization activities. Curr. Protein Pept. Sci., 2015, 16(7), 613-621.
11. Dijke, P.T.; Hill, C.S. New insights into TGF-β-Smad signalling. Trends Biochem. Sci., 2004, 29(5), 265-273.
12. Javelaud, D.; van Kempen, L.; Alexaki, V.I.; Le Scolan, E.; Luo, K.; Mauviel, A. Efficient TGF-β/SMAD signaling in human melanoma cells associated with high c-SKI/SnoN expression. Mol. Cancer, 2011, 10(1), 2.
13. Chen, J.; Li, Y.; Tian, Y.; Huang, C.; Li, D.; Zhong, Q.; Ma, X. Interaction between microbes and host intestinal health: Modulation by dietary nutrients and gut-brain-endocrine-immune axis. Curr. Protein Pept. Sci., 2015, 16(7), 592-603.
14. Liu, H.; Zhang, J.; Zhang, S.; Yang, F.; Thacker, P.A.; Zhang, G.; Qiao, S.; Ma, X. Oral administration of Lactobacillus fermentum I5007 favors intestinal development and alters the intestinal microbiota in formula-fed piglets. J. Agric. Food Chem., 2014, 62(4), 860-866.
15. Javelaud, D.; Alexaki, V.I.; Dennler, S.; Mohammad, K.S.; Guise, T.A.; Mauviel, A. TGF-β/SMAD/GLI2 signaling axis in cancer progression and metastasis. Cancer Res., 2011, 71(17), 5606-5610.
16. Hu, S.; Liu, H.; Qiao, S.; He, P.; Ma, X.; Lu, W. Development of immunoaffinity chromatographic method for isolating glycinin (11S) from soybean proteins. J. Agric. Food Chem., 2013, 61(18), 4406-4410.
17. Cordenonsi, M.; Dupont, S.; Maretto, S.; Insinga, A.; Imbriano, C.; Piccolo, S. Links between tumor suppressors: p53 is required for TGF-β gene responses by cooperating with Smads. Cell, 2003, 113(3), 301-314.
18. Cordenonsi, M.; Montagner, M.; Adorno, M.; Zacchigna, L.; Martello, G.; Mamidi, A.; Soligo, S.; Dupont, S.; Piccolo, S. Integration of TGF-β and Ras/MAPK signaling through p53 phosphorylation. Science, 2007, 315(5813), 840-843.
19. Piccolo, S. p53 regulation orchestrates the TGF-β response. Cell, 2008, 133(5), 767-769.
20. Ma, X.; Fan, P.X.; Li, L.S.; Qiao, S.Y.; Zhang, G.L.; Li, D.F. Butyrate promotes the recovering of intestinal wound healing through its positive effect on the tight junctions. J. Anim. Sci., 2013, 90(Suppl. 4), 266-268.
21. Chen, J.; Wang, J.; Song, P.; Ma, X. Determination of glycinin in soybean and soybean products using a sandwich enzyme-linked immunosorbent assay. Food Chem., 2014, 162(6), 27-33.
22. Meulmeester, E.; ten Dijke, P. The dynamic roles of TGF - β in cancer. J. Pathol., 2011, 223(2), 206-219.
23. Massagué, J.; Gomis, R.R. The logic of TGFβ signaling. FEBS Lett., 2006, 580(12), 2811-2820.
24. Yuan, X.; Zhou, Y.; Casanova, E.; Chai, M.; Kiss, E.; Gröne, H-J.; Schütz, G.; Grummt, I. Genetic inactivation of the transcription factor TIF-IA leads to nucleolar disruption, cell cycle arrest, and p53-mediated apoptosis. Mol. Cell, 2005, 19(1), 77-87.
25. Ma, X.; Hou, Y.Q.; Dahanayaka, S.; Satterfield, M.C.; Burghardt, R.C.; Bazer, F.W.; Wu, G. Technical note: Isolation and characterization of ovine brown adipocyte precursor cells. J. Anim. Sci., 2015, 93(5), 2094-2099.
26. Wade, M.; Li, Y-C.; Wahl, G.M. MDM2, MDMX and p53 in oncogenesis and cancer therapy. Nat. Rev. Cancer, 2013, 13(2), 83-96.
27. Sun, P.; Dong, P.; Dai, K.; Hannon, G.J.; Beach, D. p53-independent role of MDM2 in TGF-β1 resistance. Science, 1998, 282(5397), 2270-2272.
28. Bueso-Ramos, C.E.; Manshouri, T.; Haidar, M.A.; Yang, Y.; McCown, P.; Ordonez, N.; Glassman, A.; Sneige, N.; Albitar, M. Abnormal expression of MDM-2 in breast carcinomas. Breast Cancer Res. Treat., 1996, 37(2), 179-188.
29. Günther, T.; Schneider-Stock, R.; Ryš, J.; Niezabitowski, A.; Roessner, A. p53 gene mutations and expression of p53 and mdm2 proteins in invasive breast carcinoma. J. Cancer Res. Clin. Oncol., 1997, 123(7), 388-394.